Skip to main content

WOLVERINE ASSET MANAGEMENT LLC

Position in OGN — Organon & Co.

CIK 1279891 CHICAGO, IL

Position in OGN

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$2,815,169
+$2,719,569 QoQ
Shares Held
207,915
+1202.7% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#102
of 626 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OGN Over Time

Shares Held

Position Value (USD)

Derivatives in OGN

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$732,514
PutShares
54,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

WOLVERINE ASSET MANAGEMENT LLC holds $4,530,414 across 3 Drug Manufacturers - General names. OGN ranks #1 (62.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 OGN
Organon & Co.
This page
207,915 $2,815,169

All Filings in OGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,815,169 207,915
2026-06-30 $732,514 54,100
2026-03-31 $95,600 15,960
2026-03-31 $324,059 54,100
2025-12-31 $459,597 64,100
2025-12-31 $183,265 25,560
2025-09-30 $172,994 16,198
2025-09-30 $160,200 15,000
2025-06-30 $145,200 15,000
2025-06-30 $217,732 22,493
2025-03-31 $113,164 7,600
2025-03-31 $312,690 21,000
2024-12-31 $95,488 6,400
2024-12-31 $308,321 20,665
2024-09-30 $307,170 16,057
2024-09-30 $15,304 800
2024-06-30 $16,560 800
2024-06-30 $332,379 16,057
2024-03-31 $301,871 16,057
2024-03-31 $15,040 800
2023-12-31 $422,506 29,300
2023-12-31 $336,807 23,357
2023-09-30 $486,080 28,000
2023-06-30 $89,483 4,300
2023-03-31 $39,984 1,700
2022-12-31 $2,793 100